Vietnam Active Pharmaceutical Ingredients (API) Market - Industry Trends and Forecast to 2030
Description
Vietnam Active Pharmaceutical Ingredients (API) Market - Industry Trends and Forecast to 2030
Vietnam Active Pharmaceutical Ingredients (API) Market, By Therapeutic Class (Antibiotic, Cardiovascular, Lipid Lowering Drugs, Infectious Disease, Anesthetic, NSAIDS, Analgesic, Antiviral, Dermatology, Oncology, Endocrinology, Urology, Gastroenterology, Ophthalmology, Hormonal Agents, Muscle Relaxant, Parkinson, Psoriasis, Epileptic, Immunology, Hematology, Antineoplastic, Immunosuppressive Agents, and Others), Type ( Innovative Active Pharmaceutical Ingredient and Generic Active Pharmaceutical Ingredient), Type of Manufacturer (Captive Manufacturers and Merchant Manufacturer), Synthesis (Chemical Synthetic and Biotech), Type of Drug (Prescription Drugs and Over-the-Counter), Application (Clinical, Research), Potency (Traditional Potency Active Pharmaceutical Ingredient and High Potency Active Pharmaceutical Ingredient), Molecule (Small Molecule and Large Molecule), End User (Pharmaceutical Industries, Biotechnology Industries, Research and Academic Institutes, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Others), Country (Vietnam) – Industry Trends & Forecast to 2030.
Market Definition
In Greek, the traditional word for Active Pharmaceutical Ingredients (API) is called pharmacon or pharmakon, which symbolizes a magical substance or drug. Active pharmaceutical ingredients as described in ICH Q7 is “any substance or combination of substances intended to be used in the manufacturing of a drug product, which when used in the production of the drug, becomes an active pharmaceutical ingredient. Such substances are used to provide pharmacological activity. When more than one APIs is added to the drug, then it produces various therapeutic activities and can be used for the treatment of various diseases and control their symptoms. A small amount of active pharmaceutical ingredients is effective in providing a therapeutic effect in the body. The active pharmaceutical ingredients go under chemical changes during the manufacturing of the APIs and then it is present in the finished drug product in a modified form to provide a specific therapeutic effect.
Market Segmentation
Vietnam Active Pharmaceutical Ingredients (API) market is categorized into ten notable segments, which are based on the therapeutic class, type, type of manufacturer, synthesis, potency, type of drug, molecule, application, end user and distribution channel
• On the basis of therapeutic class, Vietnam Active Pharmaceutical Ingredients (API) market is segmented into antibiotic, cardiovascular, lipid-lowering drugs, infectious disease, anesthetic, NSAIDs, analgesic, antiviral, dermatology, oncology, endocrinology, urology, gastroenterology, ophthalmology, hormonal agents, muscle relaxant, parkinson, psoriasis, epileptic, immunology, hematology, antineoplastic, immunosuppressive agents, and others
• On the basis of type, the Vietnam active pharmaceutical ingredients (API) market is segmented into innovative active pharmaceutical ingredients and generic active pharmaceutical ingredients
• On the basis of type of manufacturer, Vietnam Active Pharmaceutical Ingredients (API) market is segmented into captive manufacturers and merchant manufacturers
• On the basis of synthesis, Vietnam Active Pharmaceutical Ingredients (API) market is segmented into chemical synthetic, and biotech. Chemical synthesis is further sub-segmented into saxagliptin, enoxaparin sodium, rufinamide, tamoxifen, artemisinin, losartan potassium, naproxen, ibuprofen acetaminophen, sodium chloride and others. The biotech segment is further sub-segmented into monoclonal antibodies, cytokines, hormones & growth factors, blood factors, recombinant vaccines, and therapeutic enzymes
• On the basis of potency, Vietnam Active Pharmaceutical Ingredients (API) market is segmented into traditional potency active pharmaceutical ingredients and high potency active pharmaceutical ingredients
• On the basis of type of drug, the Vietnam active pharmaceutical ingredients (API) market is segmented into prescription drugs and over-the-counter drugs
• On the basis of molecule, Vietnam Active Pharmaceutical Ingredients (API) market is segmented into small molecule, and large molecule
• On the basis of application, Vietnam Active Pharmaceutical Ingredients (API) market is segmented into clinical and research
• On the basis of end user, Vietnam Active Pharmaceutical Ingredients (API) market is segmented into pharmaceutical industries, biotechnology industries, research and academic institutes and other pharmaceutical industries is further segmented into large, medium, and small. Biotechnology is further segmented into large, medium, and small
• On the basis of distribution channel, Vietnam Active Pharmaceutical Ingredients (API) market is segmented into direct tenders, retail sales, and others
Market Players:
Some of the key market players for Vietnam Active Pharmaceutical Ingredients (API) market are listed below:
• Pfizer Inc.
• MEKOPHAR
• AstraZeneca
• Divi's Laboratories Limited
• Sanofi
• Dr. Reddy’s Laboratories Ltd.
• Aurobindo Pharma
• Sun Pharmaceutical Industries Ltd.
• BASF SE
• Novo Nordisk A/S
• GSK plc
• Jubilant Pharma Limited
• Lupin
• C.H. Boehringer Sohn AG & Co. KG
• Unichem Laboratories
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Vietnam Active Pharmaceutical Ingredients (API) Market, By Therapeutic Class (Antibiotic, Cardiovascular, Lipid Lowering Drugs, Infectious Disease, Anesthetic, NSAIDS, Analgesic, Antiviral, Dermatology, Oncology, Endocrinology, Urology, Gastroenterology, Ophthalmology, Hormonal Agents, Muscle Relaxant, Parkinson, Psoriasis, Epileptic, Immunology, Hematology, Antineoplastic, Immunosuppressive Agents, and Others), Type ( Innovative Active Pharmaceutical Ingredient and Generic Active Pharmaceutical Ingredient), Type of Manufacturer (Captive Manufacturers and Merchant Manufacturer), Synthesis (Chemical Synthetic and Biotech), Type of Drug (Prescription Drugs and Over-the-Counter), Application (Clinical, Research), Potency (Traditional Potency Active Pharmaceutical Ingredient and High Potency Active Pharmaceutical Ingredient), Molecule (Small Molecule and Large Molecule), End User (Pharmaceutical Industries, Biotechnology Industries, Research and Academic Institutes, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Others), Country (Vietnam) – Industry Trends & Forecast to 2030.
Market Definition
In Greek, the traditional word for Active Pharmaceutical Ingredients (API) is called pharmacon or pharmakon, which symbolizes a magical substance or drug. Active pharmaceutical ingredients as described in ICH Q7 is “any substance or combination of substances intended to be used in the manufacturing of a drug product, which when used in the production of the drug, becomes an active pharmaceutical ingredient. Such substances are used to provide pharmacological activity. When more than one APIs is added to the drug, then it produces various therapeutic activities and can be used for the treatment of various diseases and control their symptoms. A small amount of active pharmaceutical ingredients is effective in providing a therapeutic effect in the body. The active pharmaceutical ingredients go under chemical changes during the manufacturing of the APIs and then it is present in the finished drug product in a modified form to provide a specific therapeutic effect.
Market Segmentation
Vietnam Active Pharmaceutical Ingredients (API) market is categorized into ten notable segments, which are based on the therapeutic class, type, type of manufacturer, synthesis, potency, type of drug, molecule, application, end user and distribution channel
• On the basis of therapeutic class, Vietnam Active Pharmaceutical Ingredients (API) market is segmented into antibiotic, cardiovascular, lipid-lowering drugs, infectious disease, anesthetic, NSAIDs, analgesic, antiviral, dermatology, oncology, endocrinology, urology, gastroenterology, ophthalmology, hormonal agents, muscle relaxant, parkinson, psoriasis, epileptic, immunology, hematology, antineoplastic, immunosuppressive agents, and others
• On the basis of type, the Vietnam active pharmaceutical ingredients (API) market is segmented into innovative active pharmaceutical ingredients and generic active pharmaceutical ingredients
• On the basis of type of manufacturer, Vietnam Active Pharmaceutical Ingredients (API) market is segmented into captive manufacturers and merchant manufacturers
• On the basis of synthesis, Vietnam Active Pharmaceutical Ingredients (API) market is segmented into chemical synthetic, and biotech. Chemical synthesis is further sub-segmented into saxagliptin, enoxaparin sodium, rufinamide, tamoxifen, artemisinin, losartan potassium, naproxen, ibuprofen acetaminophen, sodium chloride and others. The biotech segment is further sub-segmented into monoclonal antibodies, cytokines, hormones & growth factors, blood factors, recombinant vaccines, and therapeutic enzymes
• On the basis of potency, Vietnam Active Pharmaceutical Ingredients (API) market is segmented into traditional potency active pharmaceutical ingredients and high potency active pharmaceutical ingredients
• On the basis of type of drug, the Vietnam active pharmaceutical ingredients (API) market is segmented into prescription drugs and over-the-counter drugs
• On the basis of molecule, Vietnam Active Pharmaceutical Ingredients (API) market is segmented into small molecule, and large molecule
• On the basis of application, Vietnam Active Pharmaceutical Ingredients (API) market is segmented into clinical and research
• On the basis of end user, Vietnam Active Pharmaceutical Ingredients (API) market is segmented into pharmaceutical industries, biotechnology industries, research and academic institutes and other pharmaceutical industries is further segmented into large, medium, and small. Biotechnology is further segmented into large, medium, and small
• On the basis of distribution channel, Vietnam Active Pharmaceutical Ingredients (API) market is segmented into direct tenders, retail sales, and others
Market Players:
Some of the key market players for Vietnam Active Pharmaceutical Ingredients (API) market are listed below:
• Pfizer Inc.
• MEKOPHAR
• AstraZeneca
• Divi's Laboratories Limited
• Sanofi
• Dr. Reddy’s Laboratories Ltd.
• Aurobindo Pharma
• Sun Pharmaceutical Industries Ltd.
• BASF SE
• Novo Nordisk A/S
• GSK plc
• Jubilant Pharma Limited
• Lupin
• C.H. Boehringer Sohn AG & Co. KG
• Unichem Laboratories
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Table of Contents
164 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of Vietnam Active Pharmaceutical Ingredients (Api) Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Molecule Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Vendor Share Analysis
- 2.11 Market Type Of End User Coverage Grid
- 2.12 Secondary Sources
- 2.13 Assumptions
- 3 Executive Summary
- 4 Premium Insight
- 4.1 Porter’s Five Forces
- 4.2 Pestel Analysis
- 4.3 Contact List Of Marketing Persons Involve In Purchase Of Active Pharmaceutical Ingredients
- 4.4 Pipeline Analysis For Chile Gastric Cancer Treatment Market
- 5 Regulatory Framework
- 5.1 Overview
- 5.2 Current Goods Manufacturing Practices
- 5.3 Regulatory Requirements For Registration Of Api In Vietnam
- 6 Market Overview
- 6.1 Drivers
- 6.1.1 Increasing Prevalence Of Various Chronic Disease
- 6.1.2 Increase In The Aging Population
- 6.1.3 Utilization Of Advanced Technology In Active Pharmaceutical Ingredients (Api) Manufacturing
- 6.1.4 Increasing Disease Awareness And Education
- 6.1.5 Patent Expiry Of Branded Active Pharmaceutical Ingredients (Api)
- 6.2 Restraints
- 6.2.1 Availability Of Sub-standard And Counterfeit Drugs
- 6.2.2 High Manufacturing Cost
- 6.2.3 Adverse Health Effects Of Exposure To Active Pharmaceutical Ingredients (Api)
- 6.3 Opportunities
- 6.3.1 Collaboration And Acquisition Among The Active Pharmaceutical Ingredients (Api) Manufacturers
- 6.3.2 Increasing Healthcare Expenditure
- 6.3.3 Rising Investment In Research Regarding The Development Of Active Pharmaceutical Ingredients (Api)
- 6.3.4 Soaring Number Of Active Pharmaceutical Ingredients (Api) Manufacturers
- 6.4 Challenges
- 6.4.1 Disruption In The Supply Chain Of Active Pharmaceutical Ingredients (Api) During Covid-19
- 6.4.2 Lack Of Workforce In Pharma Industries
- 7 Vietnam Active Pharmaceutical Ingredients (Api) Market, By Therapeutic Class
- 7.1 Overview
- 7.2 Antibiotic
- 7.3 Cardiovascular
- 7.4 Lipid Lowering Drugs
- 7.5 Infectious Disease
- 7.6 Anesthetic
- 7.7 Nsaids
- 7.8 Analgesic
- 7.9 Antiviral
- 7.10 Dermatology
- 7.11 Oncology
- 7.12 Endocrinology
- 7.13 Urology
- 7.14 Gastroenterology
- 7.15 Ophthalmology
- 7.16 Hormonal Agents
- 7.17 Muscle Relaxant
- 7.18 Parkinson
- 7.19 Psoriasis
- 7.20 Epileptic
- 7.21 Immunology
- 7.22 Hematology
- 7.23 Antineoplastic
- 7.24 Immunosuppressive Agents
- 7.25 Others
- 8 Vietnam Active Pharmaceutical Ingredients (Api) Market, By Type
- 8.1 Overview
- 8.2 Innovative Active Pharmaceutical Ingredient
- 8.3 Generic Active Pharmaceutical Ingredient
- 9 Vietnam Active Pharmaceutical Ingredients (Api) Market, By Type Of Manufacturer
- 9.1 Overview
- 9.2 Captive Manufacturers
- 9.2.1 Captive Innovative Active Pharmaceutical Ingredient
- 9.2.2 Captive Generic Active Pharmaceutical Ingredient
- 9.3 Merchant Manufacturers
- 9.3.1 Merchant Innovative Active Pharmaceutical Ingredient
- 9.3.2 Merchant Generic Active Pharmaceutical Ingredient
- 10 Vietnam Active Pharmaceutical Ingredients (Api) Market, By Synthesis
- 10.1 Overview
- 10.2 Chemical Synthetic
- 10.2.1 Saxagliptin
- 10.2.2 Enoxaparin Sodium
- 10.2.3 Rufinamide
- 10.2.4 Tamoxifen
- 10.2.5 Artemisinin
- 10.2.6 Losartan Potassium
- 10.2.7 Naproxen
- 10.2.8 Ibuprofen
- 10.2.9 Acetaminophen
- 10.2.10 Sodium Chloride
- 10.2.11 Others
- 10.3 Biotech
- 10.3.1 Monoclonal Antibodies
- 10.3.2 Cytokines
- 10.3.3 Hormones & Growth Factors
- 10.3.4 Blood Factors
- 10.3.5 Recombinant Vaccines
- 10.3.6 Therapeutic Enzymes Biotech
- 11 Vietnam Active Pharmaceutical Ingredients (Api) Market, By Potency
- 11.1 Overview
- 11.2 Traditional Potency Active Pharmaceutical Ingredient
- 11.3 High Potency Active Pharmaceutical Ingredient
- 12 Vietnam Active Pharmaceutical Ingredients (Api) Market, Type Of Drug
- 12.1 Overview
- 12.2 Prescription Drugs
- 12.3 Over-the-counter Drugs
- 13 Vietnam Active Pharmaceutical Ingredients (Api) Market, Molecule
- 13.1 Overview
- 13.2 Small Molecule
- 13.3 Large Molecule
- 14 Vietnam Active Pharmaceutical Ingredients (Api) Market, Application
- 14.1 Overview
- 14.2 Clinical
- 14.3 Research
- 15 Vietnam Active Pharmaceutical Ingredients (Api) Market, By End User
- 15.1 Overview
- 15.2 Pharmaceutical Industries
- 15.2.1 Large
- 15.2.2 Medium
- 15.2.3 Small
- 15.3 Biotechnology Industries
- 15.3.1 Large
- 15.3.2 Medium
- 15.3.3 Small
- 15.4 Research And Academic Institutes
- 15.5 Others
- 16 Vietnam Active Pharmaceutical Ingredients (Api) Market, By Distribution Channel
- 16.1 Overview
- 16.2 Direct Tenders
- 16.3 Retail Sales
- 16.4 Others
- 17 Vietnam Active Pharmaceutical Ingredients (Api) Market: Company Landscape
- 17.1 Company Share Analysis: Vietnam
- 18 Swot Analysis
- 19 Company Profile
- 19.1 Pfizer, Inc.
- 19.1.1 Company Snapshot
- 19.1.2 Revenue Analysis
- 19.1.3 Product Portfolio
- 19.1.4 Recent Developments
- 19.2 Mekophar
- 19.2.1 Company Snapshot
- 19.2.2 Recent Financials
- 19.2.3 Product Portfolio
- 19.2.4 Recent Development
- 19.3 Astrazeneca
- 19.3.1 Company Snapshot
- 19.3.2 Revenue Analysis
- 19.3.3 Product Portfolio
- 19.3.4 Recent Development
- 19.4 Divi’s Laboratories Limited
- 19.4.1 Company Snapshot
- 19.4.2 Revenue Analysis
- 19.4.3 Product Portfolio
- 19.4.4 Recent Developments
- 19.5 Sanofi
- 19.5.1 Company Snapshot
- 19.5.2 Revenue Analysis
- 19.5.3 Product Portfolio
- 19.5.4 Recent Developments
- 19.6 Dr. Reddy’s Laboratory Ltd.
- 19.6.1 Company Snapshot
- 19.6.2 Recent Financials
- 19.6.3 Product Portfolio
- 19.6.4 Recent Development
- 19.7 Aurobindo Pharma
- 19.7.1 Company Snapshot
- 19.7.2 Revenue Analysis
- 19.7.3 Product Portfolio
- 19.7.4 Recent Development
- 19.8 Basf Se
- 19.8.1 Company Snapshot
- 19.8.2 Recent Financials
- 19.8.3 Product Portfolio
- 19.8.4 Recent Development
- 19.9 Boehringer Ingelheim International Gmbh.
- 19.9.1 Company Snapshot
- 19.9.2 Revenue Analysis
- 19.9.3 Product Portfolio
- 19.9.4 Recent Developments
- 19.10 Gsk Plc
- 19.10.1 Company Snapshot
- 19.10.2 Revenue Financials
- 19.10.3 Product Portfolio
- 19.10.4 Recent Development
- 19.11 Jubilant Pharmova Limited
- 19.11.1 Company Snapshot
- 19.11.2 Revenue Analysis
- 19.11.3 Product Portfolio
- 19.11.4 Recent Development
- 19.12 Lupin
- 19.12.1 Company Snapshot
- 19.12.2 Revenue Analysis
- 19.12.3 Product Portfolio
- 19.12.4 Recent Developments
- 19.13 Novo Nordisk A/S
- 19.13.1 Company Snapshot
- 19.13.2 Revenue Analysis
- 19.13.3 Product Portfolio
- 19.13.4 Recent Development
- 19.14 Sun Pharmaceutical Industries Ltd.
- 19.14.1 Company Snapshot
- 19.14.2 Revenue Analysis
- 19.14.3 Product Portfolio
- 19.14.4 Recent Development
- 19.15 Unichem Laboratories
- 19.15.1 Company Snapshot
- 19.15.2 Revenue Analysis
- 19.15.3 Product Portfolio
- 19.15.4 Recent Developments
- 20 Questionnaire
- 21 Related Reports 164
- List Of Tables
- Table 1 Below Provided Table Is Providing Data Of Different Apis With Their Therapeutic Applications Under The Clinical Trial:
- Table 2 Below Are Some Manufacturers Who Are Involved In The Production Of Active Pharmaceutical Ingredients (Api):
- Table 3 Vietnam Active Pharmaceutical Ingredients (Api) Market, By Therapeutic Class, 2021-2030 (Usd Million)
- Table 4 Vietnam Active Pharmaceutical Ingredients (Api) Market, By Type, 2021-2030 (Usd Million)
- Table 5 Vietnam Active Pharmaceutical Ingredients (Api) Market, By Type Of Manufacturer, 2021-2030 (Usd Million)
- Table 6 Vietnam Captive Manufacturers In Active Pharmaceutical Ingredients (Api) Market, By Type Of Manufacturer, 2021-2030 (Usd Million)
- Table 7 Vietnam Merchant Manufacturers In Active Pharmaceutical Ingredients (Api) Market, By Type Of Manufacturer, 2021-2030 (Usd Million)
- Table 8 Vietnam Active Pharmaceutical Ingredients (Api) Market, By Synthesis, 2021-2030 (Usd Million)
- Table 9 Vietnam Chemical Synthetic In Active Pharmaceutical Ingredients (Api) Market, By Synthesis, 2021-2030 (Usd Million)
- Table 10 Vietnam Biotech In Active Pharmaceutical Ingredients (Api) Market, By Synthesis, 2021-2030 (Usd Million)
- Table 11 Vietnam Active Pharmaceutical Ingredients (Api) Market, By Potency, 2021-2030 (Usd Million)
- Table 12 Vietnam Active Pharmaceutical Ingredients (Api) Market, By Type Of Drug, 2021-2030 (Usd Million)
- Table 13 Vietnam Active Pharmaceutical Ingredients (Api) Market, By Molecule, 2021-2030 (Usd Million)
- Table 14 Vietnam Active Pharmaceutical Ingredients (Api) Market, By Molecule, 2021-2030 (Usd Million)
- Table 15 Vietnam Active Pharmaceutical Ingredients (Api) Market, By End User, 2021-2030 (Usd Million)
- Table 16 Vietnam Pharmaceutical Industries In Active Pharmaceutical Ingredients (Api) Market, By Size, 2021-2030 (Usd Million)
- Table 17 Vietnam Biotrchnology Industries In Active Pharmaceutical Ingredients (Api) Market, By Size, 2021-2030 (Usd Million)
- Table 18 Vietnam Active Pharmaceutical Ingredients (Api) Market, By Distribution Channel, 2021-2030 (Usd Million) 120
- List Of Figures
- Figure 1 Vietnam Active Pharmaceutical Ingredients (Api) Market: Segmentation
- Figure 2 Vietnam Active Pharmaceutical Ingredients (Api) Market: Data Triangulation
- Figure 3 Vietnam Active Pharmaceutical Ingredients (Api) Market: Droc Analysis
- Figure 4 Vietnam Active Pharmaceutical Ingredients (Api) Market: Global Vs Regional Market Analysis
- Figure 5 Vietnam Active Pharmaceutical Ingredients (Api) Market: Company Research Analysis
- Figure 6 Vietnam Active Pharmaceutical Ingredients (Api) Market: Multivariate Modelling
- Figure 7 Vietnam Active Pharmaceutical Ingredients (Api) Market: Interview Demographics
- Figure 8 Vietnam Active Pharmaceutical Ingredients (Api) Market: Dbmr Market Position Grid
- Figure 9 Vietnam Active Pharmaceutical Ingredients (Api) Market: Vendor Share Analysis
- Figure 10 Vietnam Active Pharmaceutical Ingredients (Api) Market: Market Type Of End User Coverage Grid
- Figure 11 Vietnam Active Pharmaceutical Ingredients (Api) Market: Segmentation
- Figure 12 Increasing Prevalence Of Various Chronic Disorders And The Rising Ageing Population Is Driving The Vietnam Active Pharmaceutical Ingredients (Api) Market In The Forecast Period Of 2023 To 2030
- Figure 13 Antibiotic Segment Is Expected To Account For The Largest Share Of The Vietnam Active Pharmaceutical Ingredients (Api) Market In 2023 To 2030
- Figure 14 Drivers, Restraints, Opportunities, And Challenges Of The Vietnam Active Pharmaceutical Ingredients (Api) Market
- Figure 15 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Therapeutic Class, 2022
- Figure 16 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Therapeutic Class, 2023-2030 (Usd Million)
- Figure 17 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Therapeutic Class, Cagr (2023-2030)
- Figure 18 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Therapeutic Class, Lifeline Curve
- Figure 19 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Type, 2022
- Figure 20 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Type, 2023-2030 (Usd Million)
- Figure 21 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Type, Cagr (2023-2030)
- Figure 22 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Type, Lifeline Curve
- Figure 23 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Type Of Manufacturer, 2022
- Figure 24 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Type Of Manufacturer, 2023-2030 (Usd Million)
- Figure 25 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Type Of Manufacturer, Cagr (2023-2030)
- Figure 26 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Type Of Manufacturer, Lifeline Curve
- Figure 27 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Synthesis, 2022
- Figure 28 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Synthesis, 2023-2030 (Usd Million)
- Figure 29 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Synthesis, Cagr (2023-2030)
- Figure 30 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Synthesis, Lifeline Curve
- Figure 31 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Potency, 2022
- Figure 32 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Potency, 2023-2030 (Usd Million)
- Figure 33 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Potency, Cagr (2023-2030)
- Figure 34 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Potency, Lifeline Curve
- Figure 35 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Type Of Drug, 2022
- Figure 36 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Type Of Drug, 2023-2030 (Usd Million)
- Figure 37 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Type Of Drug, Cagr (2023-2030)
- Figure 38 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Type Of Drug, Lifeline Curve
- Figure 39 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Molecule, 2022
- Figure 40 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Molecule, 2023-2030 (Usd Million)
- Figure 41 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Molecule, Cagr (2023-2030)
- Figure 42 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Molecule, Lifeline Curve
- Figure 43 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Application, 2022
- Figure 44 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Application, 2023-2030 (Usd Million)
- Figure 45 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Application, Cagr (2023-2030)
- Figure 46 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Application, Lifeline Curve
- Figure 47 Vietnam Active Pharmaceutical Ingredients (Api) Market: By End User, 2022
- Figure 48 Vietnam Active Pharmaceutical Ingredients (Api) Market: By End User 2023-2030 (Usd Million)
- Figure 49 Vietnam Active Pharmaceutical Ingredients (Api) Market: By End User, Cagr (2023-2030)
- Figure 50 Vietnam Active Pharmaceutical Ingredients (Api) Market: By End User, Lifeline Curve
- Figure 51 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Distribution Channel, 2022
- Figure 52 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Distribution Channel, 2023-2030 (Usd Million)
- Figure 53 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Distribution Channel, Cagr (2023-2030)
- Figure 54 Vietnam Active Pharmaceutical Ingredients (Api) Market: By Distribution Channel, Lifeline Curve
- Figure 55 Vietnam Active Pharmaceutical Ingredients (Api) Market: Company Share 2022 (%) 123
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
